Afghanistan vs Burkina Faso: The number of people with susceptibility test result for rifampicin
Afghanistan
70.58
in 2021
Burkina Faso
67.26
in 2021
Afghanistan rank
103rd
Burkina Faso rank
106th
The number of people with susceptibility test result for rifampicin over time
- Afghanistan
- Burkina Faso
How they compare
Afghanistan currently reports 70.58 against 67.26 in Burkina Faso, a difference of 3.32.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Burkina Faso ahead.
Afghanistan ranks 103rd and Burkina Faso ranks 106th of 146 countries.
Burkina Faso has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Burkina Faso | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 28.75 | 35.04 | 6.29 | Burkina Faso |
| 2020s | 57.72 | 78.72 | 21 | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Afghanistan or Burkina Faso?
- Afghanistan, at 70.58 against 67.26 in Burkina Faso as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Afghanistan and Burkina Faso?
- 3.32, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Burkina Faso?
- 5 years are reported by both, from 2017 to 2021.
- How do Afghanistan and Burkina Faso rank globally for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 103rd and Burkina Faso ranks 106th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.